# Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-and-safety-of-a-new-botulinum-toxin-type-a-free-of-complexing-proteins/

## Facts

| Field | Value |
| --- | --- |
| Author Names | P. Roggenkämper,Wolfgang H. Jost,Katalin Bihari,Georg Comes,Susanne Grafe,for the NT 201 Blepharospasm Study Team |
| Citations | 249 |
| DOI | 10.1007/s00702-005-0323-3 |
| Fields | Medicine,Neuroscience |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2027882596 |
| PMID | 15959841 |
| Type | article |
| Year | 2005 |

## Paper authors

- [Katalin Bihari](https://scholariq.org/researchers/katalin-bihari/)

## Paper journal

- [Journal of Neural Transmission](https://scholariq.org/journals/journal-of-neural-transmission/)

## Paper primary topic

- [Botulinum Toxin and Related Neurological Disorders](https://scholariq.org/topics/botulinum-toxin-and-related-neurological-disorders/)

## Paper topics

- [Botulinum Toxin and Related Neurological Disorders](https://scholariq.org/topics/botulinum-toxin-and-related-neurological-disorders/)
- [Neurological disorders and treatments](https://scholariq.org/topics/neurological-disorders-and-treatments/)
- [Hereditary Neurological Disorders](https://scholariq.org/topics/hereditary-neurological-disorders/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.